SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending as investors analyze its recent earnings beat and raised outlook, alongside news of a potential shift to the Nasdaq exchange. The community is weighing the implications of these factors, with some focusing on Walmart's strength in a tightening economy and others discussing the stock's valuation. Discussions also include the potential impact of broader economic factors, including tariffs and consumer spending habits, on Walmart's performance.

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

Safe & Green Holdings is trending due to its new integrated energy strategy and community excitement around a potential short squeeze, driven by high short interest and a low float. Traders are actively discussing the possibility of a significant price increase, drawing comparisons to other stocks with similar dynamics. The company's upcoming merger is also adding to the speculative buzz.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following positive earnings, which sparked a broader market rally and upgrades across the street. Community discussions center around the AI landscape, NVIDIA's valuation, and debate whether the company can maintain its growth trajectory. Bullish sentiment is fueled by strong Blackwell chip demand and confidence in Jensen Huang's vision.

PACS Group, Inc. is a holding company, which engages in the provision of post-acute healthcare facilities, professionals, and ancillary services. It provides senior care, assisted living, and independent living options in some of the communities. The company was founded by Jason Murray and Mark Hancock in 2013 and is headquartered in Farmington, UT.

PACS Group Inc.

PACS Group is trending due to a strong after-hours surge following its Q3 update, with investors focusing on census/occupancy trends and cash flow. Community discussions highlight the company's revenue guidance and potential analyst upgrades, with some eyeing a gap fill and higher price targets. The stock's after-hours move is attributed to healthcare expansion buzz and steady inflows.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending as investors react to recent earnings and a small dividend announcement, with some expressing disappointment. Community discussions revolve around potential buyouts, the company's book value, and the impact of global shipping rates on its performance. Despite mixed sentiment, some investors remain optimistic, citing the company's cash reserves and potential for a turnaround.

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Exact Sciences Corp.

Exact Sciences (EXAS) is trending amid news of a potential acquisition by Abbott (ABT) at $105 per share, which would give ABT leadership in the cancer screening market with Cologuard. The community is buzzing about the details of the deal and potential bidding wars, while also recognizing long-term holders who have profited from the stock's performance. Some caution that the deal isn't final, highlighting the potential for a hard retrace if talks collapse.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending amid discussions about its Q1 earnings, forward guidance, and the acquisition of Chronosphere, with investors weighing positive results against concerns about the acquisition's cost. Community members are debating whether the stock presents a buying opportunity, considering analyst ratings upgrades and the company's position in the cybersecurity sector. The stock's movement is also influenced by broader market trends and competitor performance, notably Nvidia's recent earnings.

Bath & Body Works, Inc. is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. The company was founded by Leslie Herbert Wexner in 1963 and is headquartered in Columbus, OH.

Bath & Body Works Inc

BBWI is trending due to concerns about soft Q3 results and a cut in its outlook, sparking community discussions about potential bankruptcy and missed earnings expectations. Investors are debating the company's turnaround strategy and future prospects, with some pointing to oversold conditions and undervaluation, while others express skepticism about its ability to recover. The stock's low P/E ratio and high put open interest are also key talking points.

Amentum Holdings, Inc. provides mission-critical, technology-driven services in government and commercial markets. It operates through two operating segments: Critical Mission Solutions and Cyber & Intelligence. The Critical Mission Solutions segment provides test, training, and operations services for missile defense systems, IT and engineering services to defense clients and the space sector, technological solutions, including installations, decommissioning, and environmental remediation to energy clients, and other highly technical consulting solutions. The Cyber & Intelligence segment provides advanced cyber training and data analytics for government professionals, advanced communication systems and aerial mapping technologies to national security clients, and other technical services for United States defense and intelligence clients. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum is trending as the community discusses its strong positioning in the nuclear sector and potential benefits from increased defense spending, amplified by a recent mention from Citron Research. Conversations highlight the company's global reach, alignment with key defense priorities, and potential for long-term growth, with some suggesting a possible inclusion of quarterly dividends in the future. Others are closely watching upcoming earnings and any potential impact from government contracts, with some noting recent insider buying activity.

Magnera Corp. engages in a wide range of products, including components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products serving the food and beverage industry. The company was founded on November 4, 2024 and is headquartered in Charlotte, NC.

Magnera Corp.

Magnera ($MAGN) is trending following the release of its fourth-quarter and fiscal year results, with pre-market gains sparking interest. Community discussions revolve around the stock's high institutional ownership and float, with some traders eyeing potential breakout levels while others express skepticism about the chart. Some are noting insider buys.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abbott (ABT) on Thursday said that it has entered into a definitive agreement to acquire Exact Sciences (EXAS) for up to $23 billion.Under the deal, Exact Sciences shareholders will receive $105 per common share in cash. The transaction is expected to close in the second quarter of 2026, subject to the receipt of necessary approvals.The transaction was unanimously approved by both companies' boards of directors, the companies said.&nbsp;Get updates to this developing story directly on Stocktwits.

In this photo illustration, Exact Sciences logo of a molecular diagnostics company is seen on a smartphone and a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Abbott To Acquire Exact Sciences For Up To $23B

Under the deal, Exact Sciences shareholders will receive $105 per common share in cash.

Equity

Under the deal, Exact Sciences shareholders will receive $105 per common share in cash.


Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments Abbott to acquire Exact Sciences, a leader in large and fast-growing...

<ul class="summary-bullets"><li>Shares moved premarket as Wall Street highlighted that a potential Abbott deal would likely require a valuation well above prior estimates.</li><li>William Blair said even conservative modeling supports a takeover price far higher than Exact Sciences’ recent trading range.</li><li>The interest comes as Abbott reportedly explores a major acquisition to expand its diagnostics footprint.</li></ul>Exact Sciences Corp. shares slipped over 2% in pre-market trading on Thursday even as William Blair said a potential takeover by Abbott Laboratories would “likely” need to exceed $100 per share, based on what the firm called “very conservative assumptions.” The decline came despite reports that Abbott is reportedly nearing a deal to acquire the cancer-screening company.Exact Sciences surged 24% during Wednesday’s session, marking its biggest one-day gain in nearly 16 months. Meanwhile,&nbsp;Abbott’s&nbsp;stock fell nearly 3%.<h2 class="st-heading-2">William Blair Sees Takeout Well Above $80</h2>William Blair said that Exact Sciences currently trades at just under 5x forward sales, while an acquisition would likely require a 6x to 7x sales multiple, implying a premium of over 35%. The brokerage added that its September valuation analysis already showed a fundamental path to at least $80 per share.The firm argued that Abbott would need to offer “much more than this,” pointing to a price “likely over $100.” William Blair maintains ‘Outperform’ ratings on both Abbott and Exact Sciences.<h2 class="st-heading-2">Analysts See Abbott With Capacity To Strike A Blockbuster Deal</h2>Abbott is reportedly evaluating a transaction that would significantly expand its diagnostics franchise. The company has the capacity for as much as $30 billion in debt-funded M&amp;A, supported by roughly $7 billion in annual free cash flow, according to a Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-11-19/abbott-weighs-takeover-of-cancer-test-maker-exact-sciences">report</a>.Abbott’s diagnostics business was a major boost during the Covid-19 pandemic, but sales have since dwindled. The company has recently focused more on medical devices, with its glucose-monitoring products driving growth.<h2 class="st-heading-2">Cancer Screening Remains Exact Sciences’ Core Strength</h2>Exact Sciences’ flagship colorectal screening test, Cologuard, has been used more than 20 million times since 2014. The company employs more than 6,500 people and operates nine research and lab centers across the U.S., underscoring its scale within the precision-diagnostics landscape.<h2 class="st-heading-2">Stocktwits Users Push For Higher Bids</h2>On Stocktwits, Abbott saw ‘neutral’ sentiment on ‘normal’ message volume, while Exact Sciences drew ‘extremely bullish’ sentiment amid ‘extremely high’ volume.One user said, “If<a href="https://stocktwits.com/symbol/ABT"> $ABT</a> is serious, they need to offer 25-30 billion.<a href="https://stocktwits.com/symbol/EXAS"> $EXAS</a> Shouldn't sell for less.”<stembedurl>https://stocktwits.com/ABinterceptor/message/636831161</stembedurl>Another user said, “I dare another large diagnostics to start a bidding war. Where else can you get underpenetrated CRC market leader and MCED in the same market place? Another big player can bring in more salesforce and larger marketing budget to bring Cologuard 1.0 and 2.0 to the next level.”<stembedurl>https://stocktwits.com/Jasooon/message/636852465</stembedurl>While&nbsp;<a href="https://stocktwits.com/symbol/EXAS">Exact Sciences’ stock</a> has risen 24% so far in 2025, Abbott’s stock has declined 3% over the same period.For updates and corrections, email newsroom[at]stocktwits[dot]com.

 Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover

William Blair said even conservative modeling supports a takeover price far higher than Exact Sciences’ recent trading range.

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Vanguard Group Inc. Buys 2,977,715 Shares of Abbott Laboratories $ABT

Vanguard Group Inc. raised its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 1.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities...

BSX's Neuromodulation Prospect Looks Strong: What's Behind It?

Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.

Empowered Funds LLC Has $13.80 Million Stake in Abbott Laboratories $ABT

Empowered Funds LLC boosted its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 100.1% during the second quarter, according to its most recent Form 13F filing with the...

Abbott Laboratories $ABT Holdings Lowered by America First Investment Advisors LLC

America First Investment Advisors LLC decreased its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 1.2% during the 2nd quarter, according to the company in its most recent...

Should You Continue to Hold Hologic Stock Post Q4 Earnings?

HOLX's solid Q4 growth and a pending $18.3B buyout sharpen its focus as the company prepares to end its publicly traded chapter.

Abbott Laboratories $ABT Shares Bought by Frank Rimerman Advisors LLC

Frank Rimerman Advisors LLC grew its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 33.6% in the 2nd quarter, according to the company in its most recent filing with the...

https://files.quartr.com/streams/2025-11-20/6633db3e-bb17-4534-9abd-05da8efa49e1/2/live_transcript.jsonl?ref=U3RvY2t0d2l0cw==

🚨 LIVE Earnings on Polymarket. 
Trading earnings just got much simpler: Will your favorite stock beat earnings – Yes or No?

Polymarket

Abbott Laboratories

M&A Announcement

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Current Price	$124.90
Prev Close	$130.00
Open	$129.89
Dividend Yield	1.98%
50-Day Moving Average	$130.23
Beta	0.35
Avg. Volume	6.5M
PE Ratio	15.82

52-Week High	$141.23
52-Week Low	$110.86
Market Capitalization	$246.46B
EPS (Annual)	$7.64
Price to Book	4.30
Revenue Per Employee	$367,982.46
Enterprise Value/EBITDA	N/A

ABT
Abbott Laboratories

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABT News

ABTAbbott Laboratories